Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
The DOI matches its Crossref record.
Abstract
The integrin receptor alphavbeta3 has been shown to play a critical role in several distinct processes, such as angiogenesis, osteoclast-mediated bone resorption and tumor metastasis. Its expression is upregulated in newly synthesized blood vessels produced in response to a variety of tumors and purified angiogenic factors. Studies show that alphavbeta3 is a critical target downstream from perhaps all angiogcnic factors. Proof-of-principle that alphavbeta3 antagonists such as monoclonal antibodies and small molecules block angiogenesis and tumor growth has been obtained in several animal models. Many endogenous inhibitors of angiogenesis such as angiostatin, endostatin and tumstatin seem to work through the alphavbeta3 receptor further emphasizing the critical role of this receptor in angiogenesis. In addition, the alphavbeta3 receptor has been clearly implicated in several pathological processes such as rheumatoid arthritis, osteoporosis, and metastasis of prostate cancer to bone. Thus alphavbeta3 may prove to be an important target for pharmacological intervention in more than one clinical setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical nature of integrin binding to angiogenesis is also noted in other situations such as embryogenesis, where inhibition of b 1 integrins interfere with the development of the embryonic vasculature 63 and in oncology, where integrin inhibitors are employed to inhibit tumor angiogenesis.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [64]
Citations
Cited by
Items 101–200 of 283
Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction
Kalinowski, L., Dobrucki, L. W., Meoli, D. F., Dione, D. P., Sadeghi, M. M., Madri, J. A., & Sinusas, A. J. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00861.2007 · Cited by 46
Expression of Integrins in Cerebral Arteriovenous and Cavernous Malformations
Seker, A., Yildirim, Ö., Kurtkaya, Ö., Sav, A., Günel, M., Pamir, M. N., & Kılıç, T. (2006) · Neurosurgery · doi:10.1227/01.neu.0000192174.55131.09 · Cited by 43
αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers
Belleri, M., Ribatti, D., Savio, M., Stivala, L. A., Forti, L., Tanghetti, E., Alessi, P., Coltrini, D., Bugatti, A., Mitola, S. M. F., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2351 · Cited by 42
Translating angiogenesis research into the clinic: the challenges ahead
Augustin, H. G. (2003) · British Journal of Radiology · doi:10.1259/bjr/68078705 · Cited by 41
New antiangiogenic strategies for the treatment of proliferative synovitis
Lainer, D. T., & Brahn, E. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.1.1 · Cited by 43
Cyanine Dye-Based Compounds for Tumor Imaging With and Without Photodynamic Therapy
Pandey, R. K., James, N. S., Chen, Y., & Dobhal, M. P. (2008) · Topics in heterocyclic chemistry · doi:10.1007/7081_2008_113 · Cited by 40
Popkov, M., Rader, C. M., Gonzalez, B., Sinha, S. C., & Barbas, C. F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21924 · Cited by 40
Gallo, J., Alam, I. S., Lavdas, I., Wylezinska, M., Aboagye, E. O., & Long, N. J. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21422b · Cited by 40
Zuo, H. D., Yao, W. W., Chen, T. W., Zhu, J., Zhang, J. J., Pu, Y., Liu, G., & Zhang, X. M. (2014) · BioMed Research International · doi:10.1155/2014/852352 · Cited by 38
Liu, S., Kim, Y., Hsieh, W., & Sreerama, S. G. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.08.006 · Cited by 38
Stuart, C. H., Riley, K. R., Boyacıoğlu, O., Herpai, D., Debinski, W., Qasem, S. A., Marini, F. C., Colyer, C. L., & Gmeiner, W. H. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.91 · Cited by 36
Combination of integrin siRNA and irradiation for breast cancer therapy
Cao, Q., Cai, W., Li, T., Yang, Y., Chen, K., Xing, L., & Chen, X. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.100 · Cited by 37
Whitson, R. J., Lucia, M. S., & Lambert, J. R. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24484 · Cited by 37
Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions
Zhang, K., Wang, Q., Xie, Y., Mor, G., Sega, E. I., Low, P. S., & Huang, Y. (2008) · RNA · doi:10.1261/rna.739308 · Cited by 37
Systemic Administration of siRNA via cRGD-containing Peptide
Huang, Y., Wang, X., Huang, W., Cheng, Q., Zheng, S., Guo, S., Cao, H., Liang, X., Du, Q., & Liang, Z. (2015) · Scientific Reports · doi:10.1038/srep12458 · Cited by 38
Rerat, V., Dive, G., Cordi, A. A., Tucker, G. C., Bareille, R., Amédée, J., Bordenave, L., & Marchand‐Brynaert, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901133z · Cited by 36
Antiangiogenic Activity of Semisynthetic Biotechnological Heparins
Presta, M., Oreste, P., Zoppetti, G., Belleri, M., Tanghetti, E., Leali, D., Urbinati, C., Bugatti, A., Ronca, R., Nicoli, S., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000148863.24445.b4 · Cited by 35
Integrin‐dependent translational control: Implication in cancer progression
Chung, J., & Kim, T. H. (2008) · Microscopy Research and Technique · doi:10.1002/jemt.20566 · Cited by 35
Radiotracers for SPECT imaging: current scenario and future prospects
Adak, S., Bhalla, R., Raj, K. K. V., Mandal, S., Pickett, R. D., & Luthra, S. K. (2011) · Radiochimica Acta · doi:10.1524/ract.2011.1891 · Cited by 36
Li, L., Ma, L., Shang, D., Liu, Z., Yu, Q., Wang, S., Teng, X., Zhang, Q., Hu, X., Zhao, W., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4143-8 · Cited by 36
Martínez-Jothar, L., Barendrecht, A. D., de Graaff, A. M., Oliveira, S., van Nostrum, C. F., Schiffelers, R. M., Hennink, W. E., & Fens, M. H. A. M. (2020) · Nanomaterials · doi:10.3390/nano10071353 · Cited by 35
The Rab4A Effector Protein Rabip4 Is Involved in Migration of NIH 3T3 Fibroblasts
Vukmirica, J., Monzo, P., MARCHAND‐BRUSTEL, Y. L., & Cormont, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602920200 · Cited by 32
Wang, X., Ferreira, A. M., Shao, Q., Laird, D. W., & Sandig, M. (2004) · The Prostate · doi:10.1002/pros.20168 · Cited by 32
Liu, X., Liu, K., Qin, J., Hao, L., Li, X., Liu, Y., Zhang, X., Liu, X., Li, P., Han, S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29319 · Cited by 34
Angiogenesis regulation by nanocarriers bearing RNA interference
Ofek, P., Tiram, G., & Satchi‐Fainaro, R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.01.008 · Cited by 31
Novel and Selective αvβ3 Receptor Peptide Antagonist: Design, Synthesis, and Biological Behavior
Gatto, A. D., Zaccaro, L., Grieco, P., Novellino, E., Zannetti, A., Vecchio, S. D., Iommelli, F., Salvatore, M., Pedone, C., & Saviano, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060233m · Cited by 31
A Monotargeting Peptidic Network Antibody Inhibits More Receptors for Anti-Angiogenesis
Zhang, K., Zhang, H., Gao, Y.-H., Wang, J., Li, Y., Cao, H., Hu, Y., & Wang, L. (2021) · ACS Nano · doi:10.1021/acsnano.1c02194 · Cited by 32
Wei, Y., Chen, Y., Hsiao, Y., Huang, Y., Lai, T.-H., & Tang, C. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20411 · Cited by 32
Specific Targeting of Human Integrin αvβ3 with 111In-Labeled Abegrin™ in Nude Mouse Models
Liu, Z., Jia, B., Zhao, H., Chen, X. S., & Wang, F. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0302-4 · Cited by 30
Niu, J. X., Zhang, W. J., Ye, L. Y., Wu, L. Q., Zhu, G. J., Yang, Z. H., Grau, G. E., & Lou, J. N. (2007) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3280145c00 · Cited by 35
Biltresse, S., Attolini, M. M., Dive, G., Cordi, A. A., Tucker, G. C., & Marchand‐Brynaert, J. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.055 · Cited by 30
Applications of Molecular Imaging
Galbán, C. J., Galbán, S., Dort, M. E. V., Luker, G. D., Bhojani, M. S., Rehemtulla, A., & Ross, B. D. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00009-5 · Cited by 33
Radio‐guided surgery in neuroendocrine tumors
Güleç, S. A., & Baum, R. P. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20868 · Cited by 29
Borrirukwanit, K., Lafleur, M. A., Mercuri, F. A., Blick, T., Price, J. T., Fridman, R. A., Pereira, J. J., Leardkamonkarn, V., & Thompson, E. W. (2006) · Matrix Biology · doi:10.1016/j.matbio.2006.10.014 · Cited by 38
Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold
Kaeopookum, P., Petřík, M., Summer, D., Klinger, M., Zhai, C., Rangger, C. A., Haubner, R., Haas, H., Hajdúch, M., & Decristoforo, C. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2019.09.002 · Cited by 28
MicroRNAs in malignant melanoma
Völler, D., Ott, C., & Bosserhoff, A. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.008 · Cited by 31
Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer
Lucente, E., Liu, H., Liu, Y., Hu, X., Lacivita, E., Leopoldo, M., & Cheng, Z. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00113 · Cited by 27
Xiong, S., Klausen, C., Cheng, J., Zhu, H., & Leung, P. C. K. (2015) · Oncotarget · doi:10.18632/oncotarget.5229 · Cited by 27
Zhao, D., Cao, J., Zhang, L., Zhang, S., & Wu, S. (2022) · Biosensors · doi:10.3390/bios12050342 · Cited by 31
Chung, I.-S., Son, Y., Ko, Y., Baek, C., Cho, J. K., & Jeong, H. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.01.017 · Cited by 26
Yu, H., Guo, X., Qi, X., Liu, P., Shen, X., & Duan, Y. (2007) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-007-3237-9 · Cited by 26
Localization of Collagen XVIII and Endostatin in the Human Eye
Ohlmann, A. V., Ohlmann, A., Welge‐Lüßen, U., & May, C. A. (2005) · Current Eye Research · doi:10.1080/02713680490894333 · Cited by 26
Liu, Z., Chen, W., Li, Y., & Xu, Q. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03927 · Cited by 26
Current Prospects and Challenges of Nanomedicine Delivery in Prostate Cancer Therapy
Gupta, S., Gupta, P. K., Gunasekaran, D., & Verma, R. S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0236 · Cited by 25
Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging
Ortiz-Arzate, Z., Santos‐Cuevas, C., Ocampo‐García, B., Ferro‐Flores, G., Garcı́a-Becerra, R., Estrada, G., Gómez-Argumosa, E., & Izquierdo-Sánchez, V. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000065 · Cited by 24
Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy
Polyak, D., Ryppa, C., Eldar-Boock, A., Ofek, P., Many, A., Kai, L.-C., Kratz, F., & Satchi-Fainaro, R. (2011) · Polymers for Advanced Technologies · doi:10.1002/pat.1731 · Cited by 26
18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer
Li, L., Zhao, W., Sun, X., Liu, N., Zhou, Y., Luan, X., Gao, S., Zhao, S., Yu, J., & Yuan, S. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-187 · Cited by 24
Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
Ma, K., & Hu, P. (2023) · Cancers · doi:10.3390/cancers15235652 · Cited by 25
Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma
Zhang, L., Shan, X., Meng, X., Gu, T., Guo, L., An, X., Jiang, Q. Y., Ge, H., & Ning, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00602 · Cited by 23
The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer
Zhang, L., Shan, X., Meng, X., Gu, T., Lu, Q., Zhang, J., Chen, J., Jiang, Q. Y., & Ning, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119471 · Cited by 22
αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model
Coskun, M. D., Sudha, T., Bharali, D. J., Çelikler, S., Davis, P. J., & Mousa, S. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00095 · Cited by 23
Radiotracers for different angiogenesis receptors in a melanoma model
de Oliveira, E. A., Faintuch, B. L., Núñez, E. G. F., Moro, A. M., Nanda, P. K., & Smith, C. J. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e32834e6a7e · Cited by 20
Gamble, L., Borovjagin, A. V., & Matthews, Q. L. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm_00000037 · Cited by 21
Oliveira‐Ferrer, L., Wellbrock, J., Bartsch, U., Penas, E. M. M., Hauschild, J., Klokow, M., Bokemeyer, C., Fiedler, W., & Schuch, G. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-144 · Cited by 20
Hernandez, R., Czerwiński, A. A., Chakravarty, R., Graves, S. A., Yang, Y., England, C. G., Nickles, R. J., Valenzuela, F., & Cai, W. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3085-7 · Cited by 20
Chakraborty, S., Chakravarty, R., Sarma, H. D., Dash, A. K., & Pillai, M. R. A. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1252 · Cited by 19
A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice
Swenson, S. D., Minea, R. O., Cao, D. T., Thein, T. Z., Chen, T. C., & Markland, F. S. (2018) · Molecules · doi:10.3390/molecules23112918 · Cited by 19
Kawamura, T., Yamamoto, M., Suzuki, K., Suzuki, Y., Kamishima, M., Sakata, M., Kurachi, K., Setoh, M., Konno, H., & Takeuchi, H. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy368 · Cited by 20
A highly efficient electroporation method for the transfection of endothelial cells
Hern�ndez, J. L., Coll, T., & Ciudad, C. J. (2004) · Angiogenesis · doi:10.1007/s10456-004-4180-8 · Cited by 19
New imaging techniques in cancer management
Gwyther, S. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi727 · Cited by 19
Song, X., Zhong, H., Zhou, J., Hu, X. L., Zhou, Y., Ye, Y., Lu, X., Wang, J., Ying, B., & Wang, L. (2014) · Tumor Biology · doi:10.1007/s13277-014-2903-z · Cited by 18
Fanelli, R., Schembri, L., Piarulli, U., Pinoli, M., Rasini, E., Paolillo, M., Galiazzo, M., Cosentino, M., & Marino, F. (2014) · Vascular Cell · doi:10.1186/2045-824x-6-11 · Cited by 18
Dalpati, N., Rai, S. K., Sharma, P., & Sarangi, P. P. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.12.003 · Cited by 21
Zhang, B., Liu, J.-J., Pei, D., Yang, Z., Di, J., Chen, F., Li, H., Xu, W., Wu, Y.-P., & Zheng, J.-N. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.0984 · Cited by 17
Chen, W.-T., Shih, T. T., Chen, R., Tu, S.-Y., Wen-Yuen, H., & Yang, P. (2012) · Molecular Imaging · doi:10.2310/7290.2011.00050 · Cited by 17
Li, H., Peng, W., Zhen, Z., Zhang, W., Liao, S., Wu, X., Wang, L., Xuan, A., Gao, Y., & Xu, J. (2023) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2023.108364 · Cited by 16
Importance of integrin receptors in the field of pharmaceutical & medical science
Goswami, S. (2013) · Advances in Biological Chemistry · doi:10.4236/abc.2013.32028 · Cited by 22
Osteopontin Modulates Malignant Pleural Mesothelioma Cell Functions in Vitro
Ohashi, R., Tajima, K., Cui, R., Gu, T., Hino, O., Shiomi, K., Miyamoto, H., Nishio, K., & Takahashi, K. (2009) · Haigan · doi:10.2482/haigan.49.368 · Cited by 16
Amann, K., Haas, C. S., Schussler, J., Daniel, C., Hartner, A., & Schöcklmann, H. O. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr603 · Cited by 16
Toledo, C. R., Tantawy, A. A., Fuscaldi, L. L., Malavolta, L., & Ferreira, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158553 · Cited by 19
Small Animal PET in Oncology: The Road from Bench to Bedside
Ambrosini, V., Quarta, C., Nanni, C., Pettinato, C., Franchi, R., Grassetto, G., AL-NAHHAS, A. M., Fanti, S., & Rubello, D. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2008.0554 · Cited by 15
Tumor Vasculature as a Target for Cancer Therapy
Korpanty, G. J., Huang, X., & Brekken, R. A. (2007) · Humana Press eBooks · doi:10.1385/1-59259-893-5:415 · Cited by 15
Sortase A-mediated cyclization of novel polycyclic RGD peptides for ανβ3 integrin targeting
Chen, Y., Jia, L., Zhu, G., Wang, W., Geng, M., Lu, H., Zhang, Y., Zhou, M., Zhang, F., & Cheng, X. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128888 · Cited by 14
Vatsa, R., Bhusari, P., Kumar, S., Chakraborty, S., Dash, A. K., Singh, G., Dhawan, D. K., Shukla, J., & Mittal, B. R. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1781 · Cited by 14
Pei, D., Yang, Z., Zhang, B., Yin, X., Li, L., Li, H., & Zheng, J.-N. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0040 · Cited by 14
Yacobovich, S., Tuchinsky, L., Kirby, M. L., Kardash, T., Agranyoni, O., Nesher, E., Redko, B., Gellerman, G., Tobi, D., Gurova, K. V., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11363 · Cited by 14
Dual-modified bufalin loaded liposomes for enhanced tumor targeting
Zhang, Y., Tian, Z., Zhao, X., Li, N., Garamus, V. M., Yin, P., & Zou, A. (2019) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2019.03.060 · Cited by 15
Koutsilieris, M., Bogdanos, J., Milathianakis, C., Dimopoulos, P., Dimopoulos, T., Karamanolakis, D., Halapas, A., Τέντα, Ρ., Katopodis, H., Papageorgiou, E. G., et al. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.795 · Cited by 14
Glioma cell migration and invasion as potential target for novel treatment strategies
Naumann, U., Harter, P. N., Rubel, J., Ilina, E. I., Blank, A., Esteban, H., & Mittelbronn, M. G. A. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0126-1 · Cited by 15
Peptides derived from the integrin β cytoplasmic tails inhibit angiogenesis
Cao, Z., Suo, X., Chu, Y., Zhou, X., Bao, Y., Miao, C., Deng, W., Mao, K., Gao, J., Xu, Z., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0248-8 · Cited by 14
Godugu, K., Sudha, T., Davis, P. J., & Mousa, S. A. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100395 · Cited by 15
Future opportunities for the diagnosis and treatment of prostate cancer
Watson, R. W. G., & Schalken, J. A. (2004) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500742 · Cited by 13
Sun, X., Ma, T., Liu, H., Yu, X., Wu, Y., Shi, J., Jia, B., Zhao, H., Wang, F., & Liu, Z. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2702-1 · Cited by 12
Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis
Trencsényi, G., & Képes, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087400 · Cited by 12
New Strategies for the Treatment of Metastatic Bone Disease
Pearse, R. N. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.s.010 · Cited by 13
Yu, L., Shao, F., Ji, H., Song, X., Lv, X., Xia, X., Liu, Q., Zhang, Y., Zeng, D., Lan, X., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.884554 · Cited by 11
Wang, Y., Long, L., Li, T., Zhou, Y. J., Jiang, L., Zeng, X. Y., Dan, H., Liao, G., Luo, G., Wang, H., et al. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.233.33 · Cited by 11
Yao, R., Sui, A., Wang, Z.-L., Liu, S., Zhou, Q., Liu, X., & Zhang, H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1071 · Cited by 11
Methods for Evaluation of a Snake Venom-Derived Disintegrin in Animal Models of Human Cancer
Swenson, S. D., Silva‐Hirschberg, C., & Markland, F. S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9845-6_10 · Cited by 13
Ibarra, J., Encinas-Basurto, D., Almada, M., Juárez, J., Valdez, M. A., Barbosa, S., & Taboada, P. (2023) · Micromachines · doi:10.3390/mi14071390 · Cited by 10
Shao, F., Lv, M., Zheng, Y., Jiang, J., Wang, Y., Lv, L., & Wang, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.11.004 · Cited by 10
Er, Ö., Ekşin, E., Soylu, H. M., Göçmen, B., Nalbantsoy, A., Yurt, F., & Erdem, A. (2018) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-018-2872-6 · Cited by 10
Significance of one-bead-one-compound combinational chemistry
Chen, X. S., & Gambhir, S. S. (2006) · Nature Chemical Biology · doi:10.1038/nchembio0706-351 · Cited by 10
EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF RGD-mda-7, A HIS-TAGGED mda-7/IL-24 MUTANT PROTEIN
Liu, J.-J., Zhang, B., Yin, X., Pei, D., Yang, Z., Di, J., Chen, F., Li, H., Xu, W., Wu, Y.-P., et al. (2012) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2012.659782 · Cited by 10
Targeting CD13 with Asn-Gly-Arg (NGR) Peptide-Drug Conjugates
Corti, A., Fiocchi, M., & Curnis, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-42252-7_6 · Cited by 8
Kim, Y., Kim, I., & Nam, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2055 · Cited by 9
Arrieta, O. G., García-Pérez, F. O., Michel-Tello, D., Ramírez-Tirado, L.-A., Pitalúa-Cortés, Q., Cruz‐Rico, G., Macedo-Pérez, E. O., Cardona, A. F., & de la Garza-Salazar, J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192393 · Cited by 9
Vatsa, R., Shukla, J., Kumar, S., Chakraboarty, S., Dash, A. K., Singh, G., & Mittal, B. R. (2019) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2019.2811 · Cited by 12
Morjen, M., Zakraoui, O., Abdelkafi-Koubaa, Z., Srairi‐Abid, N., Marrakchi, N., Essafi‐Benkhadir, K., & Jebali, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512427 · Cited by 8
Guleria, M., Ghosh, S., Das, T., Sarma, H. D., & Banerjee, S. (2016) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-015-4680-6 · Cited by 8
Metadata
- Authors
- Kumar, C.
- Corresponding author
- Kumar, C.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-02-01
- Volume
- 4
- Issue
- 2
- Pages
- 123-131
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W147592962
- Cited by
- 280
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 14 · 2021: 4 · 2020: 9 · 2019: 11 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 11 · 2014: 11 · 2013: 20 · 2012: 20
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, tumor angiogenesis, angiogenesis inhibitors, monoclonal antibodies, small molecule antagonists, angiostatin, endostatin, tumstatin, tumor growth, metastasis, bone metastasis, osteoclast resorption, rheumatoid arthritis, osteoporosis, therapeutic target
- MeSH terms
- Animals, Humans, Neoplasms, Neovascularization, Pathologic, Drug Delivery Systems, Angiogenesis Inhibitors, Integrin alphaVbeta3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.